Vericel Corporation reported a 26% increase in total revenue to $85.4 million for Q3 2026, driven by strong sales in its MACI and Burn Care products. Net income surged 179% to $14.2 million, with adjusted EBITDA margin reaching 30%. The company raised its full-year revenue guidance to $344-$346 million and adjusted EBITDA margin guidance to 28%, reflecting confidence in continued growth. Vericel also highlighted record product sales and expects a potential MACI launch in the U.K. in 2027, signaling ongoing expansion.
Vericel's Q3 2026 financial results provide context for readers interested in health sector dynamics. For readers following health stocks, here is Pluang's market snapshot as of Nov 05, 2026 19:01 WIB: Among 150 priced US health-sector stocks, 94 rose and 48 fell. Oscar Health Inc (OSCR) gained 5.00% to USD 36.95 with a typical hold time of 16 days and a Pluang order activity of 59% Buy. Adaptive Biotechnologies Corp (ADPT) rose 4.79% to USD 27.99, held typically for 37 days, with 100% Buy orders. Brookdale Senior Living Inc (BKD) declined 4.47% to USD 10.69, with a typical hold time of 21 days.
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...
Berkshire Hathaway's stock portfolio is now worth about three times what the company originally paid for it. These gains alone represent roughly 19% of Berkshire Hathaway's total company value, highlighting the significant growth and value generated ...
C3is Inc. will implement a one-for-five reverse stock split effective November 9, 2026, reducing its outstanding shares from about 4.2 million to 0.84 million. This move aims to increase the stock price to meet Nasdaq's minimum bid price requirement ...
Firmly secured $15 million in a Series A funding round led by Squarepoint Capital, with participation from J.P. Morgan Payments, Mastercard, and Samsung NEXT. The company provides a no-code platform that connects merchants to AI-driven shopping chann...
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
